Cite
HARVARD Citation
Hamaguchi, T. et al. (2018). Capecitabine versus S-1 as adjuvant chemotherapy for patients with stage III colorectal cancer (JCOG0910): an open-label, non-inferiority, randomised, phase 3, multicentre trial. Lancet gastroenterology and hepatology. pp. 47-56. [Online].